Lessons Learned From Talking With Parents About the Role of Hematopoietic Stem Cell Transplantation in the Treatment of Children With Sickle Cell Disease

References

• van der Plas EM, van den Tweel XW, Geskus RB, et al. Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening. Br J Haematol. 2011;155:106-110.
   PubMed Web of Science ®Google Scholar
• Sheth S, Licursi M, Bhatia M. Sickle cell disease: time for a closer look at treatment options? Br J Haematol. 2013;162:455-464.
   PubMed Web of Science ®Google Scholar
• Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447-3452.
   PubMed Web of Science ®Google Scholar
• King A, Shenoy S. Evidence-based review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia. Blood. 2014;123:3089-3094.
   PubMed Web of Science ®Google Scholar
• Sickle Cell Disease Association of America. Sickle Cell Disease Global. http://www.sicklecelldisease.org/index.cfm?page = scd-global. Updated 2014. Accessed August 20, 2014.
   Google Scholar
• Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;4(Suppl 4):S398-S405.
   Google Scholar
• Fernandes AP, Januario JN, Cangussu CB, Macedo DL, Viana MB. Mortality of children with sickle cell disease: a population study. J Pediatr (Rio J). 2010;86(4):279-284.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997;89:1787-1792.
   PubMed Web of Science ®Google Scholar
• Lanzkron S, Carroll CP, Haywood C Jr. Mortality rates and age at death from sickle cell disease: US, 1979–2005. Public Health Rep. 2013;128(2):110-116.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 2010;115:2354-2363.
   PubMed Web of Science ®Google Scholar
• Ballas SK. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol. 2001;38(Suppl 1):30-36.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Pagliara D. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease. Pediatr Blood Cancer. 2012;59:372-376.
   PubMed Web of Science ®Google Scholar
• Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT III. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med. 1984;311:780-783.
   PubMed Web of Science ®Google Scholar
• Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000;95:1918-1924.
   PubMed Web of Science ®Google Scholar
• Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998;22:1-6.
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110:2749-2756.
   PubMed Web of Science ®Google Scholar
• Dalle J-H. Hematopoietic stem cell transplantation for hemoglobinopathies. Paper presented at: European Society for Blood and Marrow Transplantation Annual Meeting; April 3-6, 2011; Paris, France.
   Google Scholar
• Panepinto JA, Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol. 2007;137:479-485.
   PubMed Web of Science ®Google Scholar
• Soni S, Gross TG, Rangarajan H, Baker KS, Sturm M, Rhodes M. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin. Pediatr Blood Cancer. 2014;61:1685-1689.
   PubMed Web of Science ®Google Scholar
• Dallas MH, Triplett B, Shook DR, et al. Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2013;19:820-830.
   PubMed Web of Science ®Google Scholar
• Matthes-Martin S, Lawitschka A, Fritsch G, et al. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease. Eur J Haematol. 2013;90:308-312.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Jin Z, Geyer MB, et al. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant. 2014;49:913-920.
   PubMed Web of Science ®Google Scholar
• Shenoy S. Has stem cell transplantation come of age in the treatment of sickle cell disease? Bone Marrow Transplant. 2007;40:813-821.
   PubMed Web of Science ®Google Scholar
• Khoury R, Abboud MR. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011;4:343-351.
   PubMed Web of Science ®Google Scholar
• Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant. 2005;35(2):171-177.
   PubMed Web of Science ®Google Scholar
• Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519-528.
   PubMed Web of Science ®Google Scholar
• Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361:2309-2317.
   PubMed Web of Science ®Google Scholar
• Center for International Blood and Marrow Transplant, a contractor for the C.W. Bill Young Cell Transplantation Program operated through the US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau. US Patient Survival Report. http://bloodcell.transplant.hrsa.gov/research/transplant_data/us_tx_data/survival_data/survival.aspx. Accessed August 20, 2014.
   Google Scholar
• Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996;335:369-376.
   PubMed Web of Science ®Google Scholar
• Shenoy S. Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends. Hematology Am Soc Hematol Educ Program. 2011;2011:273-279.
   PubMedGoogle Scholar
• Dresse MF, Beguin Y. Haematopoietic stem cell transplantation for children in Belgium. Journal du Pédiatre Belge. 2008;1:44-51.
   Google Scholar
• Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 2008;41(2):109-117.
   PubMed Web of Science ®Google Scholar
• Center for International Blood and Marrow Transplant, a contractor for the C.W. Bill Young Cell Transplantation Program operated through the US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau. US Transplant Data by Disease Report. http://bloodcell.transplant.hrsa.gov/research/transplant_data/us_tx_data/index.html. Published unknown. Accessed August 20, 2014.
   Google Scholar
• Walters MC, Patience M, Leisenring W, et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 1996;2(2):100-104.
   PubMedGoogle Scholar
• Hansbury EN, Schultz WH, Ware RE, Aygun B. Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions. Pediatr Blood Cancer. 2012;58:611-615.
   PubMed Web of Science ®Google Scholar
• Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol. 1994;16:27-29.
   PubMedGoogle Scholar
• van Besien K, Koshy M, Anderson-Shaw L, et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone Marrow Transplant. 2001;28:545-549.
   PubMed Web of Science ®Google Scholar
• Kodish E, Lantos J, Stocking C, Singer PA, Siegler M, Johnson FL. Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Engl J Med. 1991;325(19):1349-1353.
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant. 2007;39:447-451.
   PubMed Web of Science ®Google Scholar
• Dong A, Rivella S, Breda L. Gene therapy for hemoglobinopathies: progress and challenges. Transl Res. 2013;161:293-306.
   PubMed Web of Science ®Google Scholar
• Lucarelli G, Gaziev J, Isgro A, et al. Allogeneic cellular gene therapy in hemoglobinopathies—evaluation of hematopoietic SCT in sickle cell anemia. Bone Marrow Transplant. 2012;47:227-230.
   PubMed Web of Science ®Google Scholar
• Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for children with sickle cell disease. Cochrane Database Syst Rev. 2009 (1):CD007001.
   Google Scholar
• Hankins J, Hinds P, Day S, et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer. 2007;48:705-710.
   PubMed Web of Science ®Google Scholar
• O'Brien SH, Hankins JS. Decision analysis of treatment strategies in children with severe sickle cell disease. J Pediatr Hematol Oncol. 2009;31:873-878.
   PubMed Web of Science ®Google Scholar
• Kelly MJ, Pennarola BW, Rodday AM, Parsons SK. Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatr Blood Cancer. 2012;59:725-731.
   PubMed Web of Science ®Google Scholar
• Panepinto JA, Torres S, Varni JW. Development of the PedsQL Sickle Cell Disease Module items: qualitative methods. Qual Life Res. 2012;21:341-357.
   PubMed Web of Science ®Google Scholar
• Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther. 2003;3:1215-1224.
   PubMed Web of Science ®Google Scholar
• Jae GA, Lewkowitz AK, Yang JC, Shen L, Rahman A, Del Toro G. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents. Ethn Health. 2011;16:431-445.
   PubMed Web of Science ®Google Scholar
• Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health. 1997;2:31-45.
   PubMedGoogle Scholar
• Branson RD, Davis K Jr, Butler KL. African Americans' participation in clinical research: importance, barriers, and solutions. Am J Surg. 2007;193:32-39. discussion 40.
   PubMed Web of Science ®Google Scholar
• Adderley-Kelly B, Green PM. Strategies for successful conduct of research with low-income African American populations. Nurs Outlook. 2005;53(3):147-152.
   PubMed Web of Science ®Google Scholar
• Liem RI, Cole AH, Pelligra SA, Mason M, Thompson AA. Parental attitudes toward research participation in pediatric sickle cell disease. Pediatr Blood Cancer. 2010;55:129-133.
   PubMed Web of Science ®Google Scholar
• Vassiliou G, Amrolia P, Roberts IA. Allogeneic transplantation for haemoglobinopathies. Best Pract Res Clin Haematol. 2001;14:807-822.
   PubMed Web of Science ®Google Scholar
• Vermylen C, Cornu G. Hematopoietic stem cell transplantation for sickle cell anemia. Curr Opin Hematol. 1997;4:377-380.
   PubMedGoogle Scholar